Clinical Trial Update: Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update investigating pembrolizumab and trastuzumab for HER2-positive gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Yonsei University | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN